Achillion pharmaceuticals inc (ACHN)
Balance Sheet / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

43,567

34,876

49,491

49,829

36,291

35,121

36,922

43,496

52,094

35,391

43,079

77,261

40,362

33,777

58,745

81,725

150,431

61,698

46,723

73,664

39,610

33,268

34,121

33,457

25,630

17,237

39,398

18,526

20,841

18,264

29,489

16,110

23,388

81,925

25,373

Marketable securities

110,121

-

-

221,148

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

152

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

198,498

204,577

-

245,775

251,624

266,942

256,578

269,636

315,064

336,022

286,558

368,343

391,429

381,102

377,616

312,277

184,051

206,518

79,215

-

-

-

88,393

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

87,009

98,205

106,417

-

114,138

116,583

105,595

46,884

60,066

41,692

35,087

37,456

41,751

17,652

29,827

Accounts and other receivables

236

415

1,216

350

82

318

350

60

291

229

459

15,256

385

886

917

506

378

741

806

95

42

194

633

480

36

609

589

277

463

426

17

103

93

363

246

Unbilled accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

711

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

3,764

3,719

3,806

4,053

4,286

4,842

5,286

3,804

4,985

4,472

3,866

3,460

2,753

3,008

2,277

2,741

2,172

2,315

1,531

1,901

2,016

1,923

1,460

2,452

2,129

2,619

3,775

2,180

2,290

1,935

2,380

1,423

2,033

1,907

2,052

Total current assets

157,840

237,508

259,090

275,380

286,434

291,905

309,500

303,938

327,006

355,156

383,426

382,535

411,843

429,100

443,041

462,588

465,258

249,516

255,578

154,875

128,677

133,590

142,631

124,782

141,933

137,048

149,357

67,867

83,660

62,317

66,973

55,092

67,265

101,847

57,498

Marketable securities

75,274

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

7,931

-

-

-

7,928

2,989

30,511

30,065

18,268

6,273

27,657

-

-

3,034

-

12,182

14,511

21,914

-

-

-

-

36,139

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,671

-

32,692

52,352

54,946

12,008

9,741

-

5,453

26,377

24,861

-

-

Fixed assets, net

949

1,458

1,858

2,137

2,400

2,606

2,737

2,816

3,013

3,135

3,281

3,479

3,145

3,019

2,377

1,735

1,880

1,871

1,718

1,726

1,581

1,279

1,372

1,265

1,205

1,297

1,301

1,247

1,308

1,364

1,371

994

1,060

825

468

Operating lease right of use asset

2,265

1,317

1,563

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

14

9

14

189

191

198

188

196

206

208

221

52

53

84

52

50

-

-

-

54

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39

41

53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

161

161

156

79

79

79

79

256

10

12

13

15

17

10

117

Restricted cash

-

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

152

Total assets

236,342

248,375

262,677

277,858

289,177

302,789

315,566

337,613

360,442

376,919

393,353

413,875

415,193

432,355

448,656

464,525

479,511

266,091

279,415

156,807

130,571

135,182

147,982

162,417

176,061

190,928

205,835

81,530

94,871

63,845

73,962

82,630

93,355

102,834

58,235

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

3,144

4,590

2,015

2,335

1,597

1,390

2,445

5,253

8,133

2,956

4,128

7,002

5,449

5,811

6,583

4,133

4,946

11,547

8,015

6,418

2,636

2,004

3,641

4,591

4,845

6,561

5,193

4,276

5,866

4,868

4,896

4,795

4,175

4,168

2,672

Accrued expenses

13,710

10,771

10,091

9,363

6,871

6,584

5,542

7,461

6,102

10,805

6,187

6,618

8,078

6,795

6,653

10,302

12,726

12,053

4,786

6,446

8,222

7,039

5,636

4,521

6,367

6,932

5,031

4,510

6,549

4,722

4,169

4,008

4,092

3,735

2,061

Current portion of operating lease liability

754

861

1,073

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31,592

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt

-

-

-

131

156

153

151

170

201

259

316

351

234

230

227

223

219

216

213

195

110

164

256

291

326

361

356

350

345

339

333

141

139

137

469

Total current liabilities

17,608

16,222

13,179

11,829

8,624

8,127

8,138

12,884

14,436

14,020

10,631

13,971

13,761

12,836

13,463

14,658

49,483

23,816

13,014

13,059

10,968

9,207

9,533

9,403

11,538

13,854

10,580

9,136

12,760

9,929

9,398

8,944

8,406

8,040

5,202

Long-term portion of operating lease liability

1,518

510

559

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

-

-

-

17

34

50

66

83

100

116

133

149

166

150

152

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt

-

-

-

-

13

53

92

131

169

207

243

301

55

114

173

231

288

345

400

279

-

-

-

56

110

164

255

347

436

524

-

229

265

301

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

2,489

2,489

2,489

2,489

Long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

611

-

-

-

-

Total liabilities

19,126

16,732

13,738

11,846

8,671

8,230

8,296

13,098

14,705

14,343

11,007

14,421

13,982

13,100

13,788

14,889

49,771

24,161

13,414

13,338

10,968

9,207

9,533

9,459

11,648

14,018

10,835

9,483

13,196

10,453

10,009

11,662

11,160

10,830

7,691

Commitments and contingencies (Note 11)

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred Stock, undesignated, $.01 par value; 5,000 shares authorized at December 31, 2012 and 2011; no shares issued or outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

Common Stock, $0.001 par value; 300,000 and 200,000 shares authorized at September 30, 2019 and December 31, 2018, respectively; 139,891 and 138,716 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively

140

139

139

139

139

139

138

138

138

137

137

137

137

137

137

137

137

118

118

104

100

98

97

97

97

97

97

80

80

72

71

70

70

70

58

Additional paid-in capital

947,747

942,522

940,564

938,998

936,900

935,280

931,059

927,420

925,113

922,672

919,762

916,584

913,753

911,066

908,232

905,256

902,257

740,767

735,780

599,796

548,596

539,271

536,090

534,529

532,631

531,359

529,399

394,675

393,073

349,576

348,595

346,518

345,383

344,707

281,878

Stock subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,737

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-730,894

-711,311

-691,885

-672,926

-656,325

-640,441

-623,242

-602,654

-579,451

-560,113

-537,570

-517,418

-512,989

-492,259

-473,766

-455,712

-472,664

-498,923

-469,945

-450,682

-429,086

-413,419

-397,762

-381,674

-368,324

-354,405

-334,465

-322,727

-311,523

-296,268

-284,741

-275,600

-263,215

-252,777

-231,394

Accumulated other comprehensive income (loss)

223

293

121

-199

-208

-419

-685

-389

-63

-120

17

151

310

311

265

-45

10

-32

48

-12

-7

25

24

6

9

-141

-31

19

45

12

28

-20

-43

4

2

Total stockholders’ equity

217,216

231,643

248,939

266,012

280,506

294,559

307,270

324,515

345,737

362,576

382,346

399,454

401,211

419,255

434,868

449,636

429,740

241,930

266,001

143,469

119,603

125,975

138,449

152,958

164,413

176,910

195,000

72,047

81,675

53,392

63,953

70,968

82,195

92,004

50,544

Total liabilities and stockholders’ equity

236,342

248,375

262,677

277,858

289,177

302,789

315,566

337,613

360,442

376,919

393,353

413,875

415,193

432,355

448,656

464,525

479,511

266,091

279,415

156,807

130,571

135,182

147,982

162,417

176,061

190,928

205,835

81,530

94,871

63,845

73,962

82,630

93,355

102,834

58,235